Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases (Q44387101)

2 December 2017

title

Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases (English)

1 reference

2 December 2017

Garrett M Morris

5

0 references

author name string

Chi Ching Mak

1

1 reference

2 December 2017

Ashraf Brik

2

1 reference

2 December 2017

Danica L Lerner

3

1 reference

2 December 2017

John H Elder

4

1 reference

2 December 2017

Arthur J Olson

6

1 reference

2 December 2017

Chi-Huey Wong

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Bioorganic & Medicinal Chemistry

2 December 2017

published in

1 reference

2 December 2017

volume

11

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

2025-2040

1 reference

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Protease inhibitors: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

The not-so-great escape

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Current knowledge and future prospects for the use of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Structural mechanisms of HIV drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Nucleotide sequence and genomic organization of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Design, synthesis, and conformational analysis of a novel macrocyclic HIV-protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Regioselective structural and functional mimicry of peptides. Design of hydrolytically-stable cyclic peptidomimetic inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Substrate-Based Cyclic Peptidomimetics of Phe-Ile-Val That Inhibit HIV-1 Protease Using a Novel Enzyme-Binding Mode

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

A Novel Bicyclic Enzyme Inhibitor as a Consensus Peptidomimetic for the Receptor-Bound Conformations of 12 Peptidic Inhibitors of HIV-1 Protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Paracyclophanes: a novel class of water-soluble inhibitors of HIV proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Intriguing structure-activity relations underlie the potent inhibition of HIV protease by norstatine-based peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

Development of selective tight-binding inhibitors of leukotriene A4 hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900054-3

7 January 2021

10.1016/S0968-0896(03)00054-3

Identifiers

DOI

1 reference

2 December 2017

1 reference